telehealth services new jersey compounded glp-1 receptor agonist weight loss FDA CRACKDOWN ESCALATES: 30 companies hit with warning letters for false claims on drugs. The agency accuses firms of misleading consumers by implying unapproved compounded versions match FDA-approved medications GLP-1 Telehealth Is Changing Fast

Semaglutide GLP-1 and Ozempic are essentially the same, as Ozempic is a brand name for semaglutide, both containing the same active ingredient

Although statistical significance was not achieved, a similar trend was seen for the peptides administered via the intestine

Metabolic disorders are on the rise in China, India, and Japan due to urbanization and lifestyle booms

The conventional wisdom held that peptide hormones could never become practical drugsthey were too unstable, too expensive, too difficult

Its FDA approval specifically for weight loss in 2021 opened the floodgates for prescriptions to people without diabetes, a population that the studies suggest may face even higher risks for certain complications like NAION